Aurora Cannabis Beheer

Beheer criteriumcontroles 2/4

De CEO Aurora Cannabis is Miguel Martin, benoemd in Sep2020, heeft een ambtstermijn van 4.17 jaar. De totale jaarlijkse vergoeding van { bedraagt CA$ 8.02M, bestaande uit 9.7% salaris en 90.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.32% van de aandelen van het bedrijf, ter waarde $ 770.61K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.8 jaar en 4.2 jaar.

Belangrijke informatie

Miguel Martin

Algemeen directeur

CA$8.0m

Totale compensatie

Percentage CEO-salaris	9.7%
Dienstverband CEO	4.2yrs
Eigendom CEO	0.3%
Management gemiddelde ambtstermijn	3.8yrs
Gemiddelde ambtstermijn bestuur	4.2yrs

Recente managementupdates

Recent updates

Aurora Cannabis: Revving Up To Profitability

Aug 08

Aurora launches new cannabis products for adult and medical-use

Oct 17

Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes

Oct 07

Is Aurora Cannabis Stock A Buy Or Sell Before Upcoming Earnings? Buy The U.S. Opportunity

Sep 16

Aurora Cannabis Is A Pass For Now, Although We Are Bullish On The Industry

Jun 05

Aurora Cannabis: Extreme Downside Case Averted

Feb 02

Analyse CEO-vergoeding

Hoe is Miguel Martin's beloning veranderd ten opzichte van Aurora Cannabis's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-CA$30m
Jun 30 2024	n/a	n/a	-CA$30m
Mar 31 2024	CA$8m	CA$774k	-CA$55m
Dec 31 2023	n/a	n/a	-CA$116m
Sep 30 2023	n/a	n/a	-CA$153m
Jun 30 2023	n/a	n/a	-CA$195m
Mar 31 2023	CA$7m	CA$591k	-CA$793m
Dec 31 2022	n/a	n/a	-CA$2b
Sep 30 2022	n/a	n/a	-CA$2b
Jun 30 2022	CA$5m	CA$713k	-CA$2b
Mar 31 2022	n/a	n/a	-CA$1b
Dec 31 2021	n/a	n/a	-CA$381m
Sep 30 2021	n/a	n/a	-CA$607m
Jun 30 2021	CA$4m	CA$694k	-CA$692m

Compensatie versus markt: De totale vergoeding ($USD 5.73M ) Miguel } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 1.46M ).

Compensatie versus inkomsten: De vergoeding van Miguel is gestegen terwijl het bedrijf verliesgevend is.

CEO

Miguel Martin (51 yo)

4.2yrs

Tenure

CA$8,015,234

Compensatie

Mr. Miguel Martin is Executive Chairman of Aurora Cannabis Inc. from September 20, 2024 and has been the Chief Executive Officer since September 08, 2020 and has been its Director since September 2020 and...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Miguel Martin	CEO & Executive Chairman	4.2yrs	CA$8.02m	0.32% $ 770.6k
Simona King	Chief Financial Officer	less than a year	CA$381.19k	geen gegevens
Alex Miller	Executive Vice President of Operations & Supply Chain	2.7yrs	CA$1.38m	0.0042% $ 9.9k
Nathalie Clark	Executive VP	2.7yrs	CA$1.35m	0.00049% $ 1.2k
Andre Jerome	Executive Vice President of Global Business Development	6.8yrs	CA$1.29m	0.038% $ 89.1k
Ananth Krishnan	Vice President of Capital Markets & Investor Relations	no data	geen gegevens	geen gegevens
Michelle Lefler	Vice President of Communications & Public Relations	no data	geen gegevens	geen gegevens
Lori Schick	Executive Vice President of Human Resources	3.5yrs	CA$1.61m	0.024% $ 56.2k
Jonathan Page	Senior Science Advisor	6yrs	geen gegevens	geen gegevens
Rick Savone	Senior Vice President of Global Government Relations	4.9yrs	geen gegevens	geen gegevens
David Aird	Executive Vice President of Information Technology	2.3yrs	geen gegevens	geen gegevens
Thomas Larssen	President of Aurora Larssen Projects Ltd.	6.9yrs	geen gegevens	geen gegevens

3.8yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van ACB wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Miguel Martin	CEO & Executive Chairman	4.2yrs	CA$8.02m	0.32% $ 770.6k
Ronald Funk	Lead Independent Director	6.3yrs	CA$289.99k	0.010% $ 24.6k
Theresa Firestone	Independent Director	3.3yrs	CA$235.00k	0.0063% $ 15.0k
Rajesh Uttamchandani	Independent Director	less than a year	geen gegevens	geen gegevens
Michael Singer	Independent Director	8.5yrs	CA$219.99k	0.013% $ 31.8k
Norma Beauchamp	Independent Director	6.3yrs	CA$235.00k	geen gegevens
Chitwant Kohli	Independent Director	2.8yrs	CA$238.91k	0.011% $ 26.0k

4.2yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van ACB wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).

Aurora Cannabis Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Aurora Cannabis Inc. Announces Board Changes and Changes to Board Committee Compositions

Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors

Aurora Cannabis Inc. Announces CFO Changes

CEO & Director recently bought US$98k worth of stock

Aurora Cannabis Inc., Annual General Meeting, Aug 14, 2023

Aurora Cannabis Inc., Annual General Meeting, Nov 14, 2022

Recent updates

Aurora Cannabis Inc. Expands Innovative Recreational Product Portfolio

New minor risk - Profitability

Forecast to breakeven in 2026

Aurora Cannabis Inc. Announces Notice of Proposed Settlement of Class Action Involving All Persons and Entities Who Purchased Aurora Cannabis Inc. Common Stock Between October 23, 2018 and February 28, 2020, Inclusive

Second quarter 2025 earnings released: EPS: CA$0.05 (vs CA$0.048 in 2Q 2024)

Aurora Cannabis Inc. to Report Q2, 2025 Results on Nov 06, 2024

Aurora Cannabis Inc. Announces Board Changes and Changes to Board Committee Compositions

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Aurora Cannabis: Revving Up To Profitability

Aurora Cannabis Inc. to Report Q1, 2025 Results on Aug 07, 2024

New minor risk - Profitability

Full year 2024 earnings released: CA$1.28 loss per share (vs CA$8.22 loss in FY 2023)

Forecast breakeven date pushed back to 2027

Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors

Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products

New minor risk - Share price stability

Aurora Cannabis Inc. Announces CFO Changes

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New major risk - Shareholder dilution

New minor risk - Profitability

Aurora Cannabis Inc. (TSX:ACB) acquired remaining 90% stake in Indica Industries Pty Ltd for AUD 45 million.

Aurora Cannabis Inc. Provides Earnings Guidance for the Fourth Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q3, 2024 Results on Feb 08, 2024

Forecast to breakeven in 2026

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for Third Quarter of Fiscal 2024

Aurora Cannabis Inc. to Report Q2, 2024 Results on Nov 09, 2023

New major risk - Shareholder dilution

Aurora Cannabis Inc. has completed a Follow-on Equity Offering in the amount of CAD 38.826875 million.

New major risk - Financial position

Aurora Cannabis Inc. Provides Revenue Guidance for the Second Quarter of Fiscal Year 2024

Aurora Cannabis Inc. to Report Q1, 2024 Results on Aug 10, 2023

Bevo Farms Ltd acquired Medicine Hat, Alberta Aurora Sun Facility from Aurora Cannabis Inc. (TSX:ACB) for CAD 15 million.

Now 21% undervalued after recent price drop

CEO & Director recently bought US$98k worth of stock

New minor risk - Profitability

Third quarter 2023 earnings released: CA$0.24 loss per share (vs CA$4.72 loss in 3Q 2022)

Aurora Cannabis Inc. to Report Fiscal Year 2023 Results on Jun 14, 2023

Aurora Celebrates Summer with New Innovation Launching Across Canada

Aurora Cannabis Inc., Annual General Meeting, Aug 14, 2023

Forecast to breakeven in 2026

Aurora Cannabis Inc. Reports Impairment Changes for the Quarter Ended December 31, 2022

Second quarter 2023 earnings released

Aurora Cannabis Inc. to Report Q2, 2023 Results on Feb 09, 2023

An Unknown buyer acquired Aurora Polaris facility from Aurora Cannabis Inc. for CAD15 million.

Now 20% undervalued after recent price drop

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Forecast to breakeven in 2025

First quarter 2023 earnings released: CA$0.17 loss per share (vs CA$0.06 loss in 1Q 2022)

Aurora Cannabis Inc. to Report Q1, 2023 Results on Nov 10, 2022

Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

Aurora Announces Unprecedented Fall Product Release Across Adult-Use and Medical Markets

Aurora launches new cannabis products for adult and medical-use

Aurora Cannabis further strengthens its balance sheet by repurchasing ~US$23M of convertible notes

Full year 2022 earnings: Revenues in line with analyst expectations

Aurora Cannabis Q4 2022 Earnings Preview

Aurora Cannabis Inc. to Report Q4, 2022 Results on Sep 20, 2022

Aurora Cannabis Inc., Annual General Meeting, Nov 14, 2022

Aurora Cannabis Inc. (TSX:ACB) acquired 50.1% stake in Bevo Agtech Inc. for CAD 57 million.

Aurora Cannabis: Don't Let Your Money Go Up In Smoke

Why Did Aurora Cannabis Stock Crash In May; Can It Recover?

Independent Director recently bought US$66k worth of stock

Aurora Cannabis Inc. has completed a Composite Units Offering in the amount of $150.00125 million.

Aurora Cannabis Inc. has completed a Composite Units Offering in the amount of $125.195 million.

Aurora Cannabis Inc. Reports Impairment Chargers for the Three Months Ended March 31, 2022

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Recent Developments Do Not Change Our Stance On Aurora Cannabis

Aurora Cannabis Inc. (TSX:ACB) completed the acquisition of TerraFarma, Inc. for CAD 38 million.

Aurora Cannabis: A Train Wreck Desperate For Help